Projects

doc. MUDr. Richard Imrich, DrSc.
Researcher

International

Current
  • European partnership fostering a European Research Area (ERA) for health research
    Program: Horizon Europe
    Duration: 1. 11. 2022 – 30. 10. 2029
Finished
  • Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren\'s Syndrome
    Program: Multilateral - other
    Duration: 1. 1. 2008 – 31. 12. 2012
  • Rheumatoid arthritis susceptibility genes in Austrian and Slovak population
    Program: INTERREG
    Duration: 1. 7. 2009 – 30. 9. 2012
  • Central Europe Research to Innovation Models
    Program: Multilateral - other
    Duration: 22. 10. 2008 – 30. 9. 2011

National

Current
  • Modified regulatory T cells for therapy of multiple sclerosis
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • Effects of GLP-1 Analog on Multiple Sclerosis
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
Finished
  • Hepatic, lipid and cardiometabolic parameters changes in obese patients
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Immune response to SARS-CoV-2 infection and development of clinically relevant virological tests to improve the management of the COVID-19 pandemic
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • GLP-1 analogues usage in the treatment of multiple sclerosis
    Program: Other projects
    Duration: 1. 12. 2018 – 31. 3. 2021
  • Multiple sclerosis - The role of mitochondrial dysfunction in insulin resistance.
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • The role of myokines and adipokines in improvement of the cardiometabolic parameters following lifestyle changes in sedentary subjects
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • Functional Consequences of C1858T Polymorphism in PTPN22 Gene on T cell differentiation: A Bioinformatic Approach.
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • -
    Program: EU Structural Funds Research & Development
    Duration: 1. 10. 2011 – 31. 1. 2015
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 1. 2014
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 10. 2013
  • Diagnoses of Socially Important Diseases in Slovakia Based on Modern Biotechnologies.
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 10. 2013
  • Single Nucleotide Polymorphism C1858T in PTPN22 Gene in Slovak Population of Patients with Rheumatoid Arthritis
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Development of the Centre for Molecular Medicine of the Slovak Academy of Sciences as a unique modern clinical research unit in Slovakia
    Program:
    Duration: 1. 8. 2009 – 31. 3. 2011
Employees